Merck & Co Inc (LTS:0QAH)
$ 131.3 0 (0%) Market Cap: 249.37 Bil Enterprise Value: 272.91 Bil PE Ratio: 20.67 PB Ratio: 5.61 GF Score: 81/100

Merck & Co Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 03, 2021 / 06:20PM GMT
Release Date Price: $70.78
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good afternoon, and welcome to the Merck session of Cowen's 41st Annual Health Care Conference. We're very pleased to have Merck back with us again this year. Representing the company is Frank Clyburn, who is Chief Commercial Officer; as well as Peter Dannenbaum, who is the global Head of Investor Relations. So we appreciate you both being here with us today.

Questions & Answers

Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Merck had a solid year in 2020. Frank, as you peer into 2021, what do you see as the pushes and pulls to the year? What do you think will maybe go better than expected? What do you think could be a little bit more challenging?

Franklin K. Clyburn
Merck & Co., Inc. - Chief Commercial Officer & Executive VP

Sure, Steve. So thanks for having us, and it's great to be here this afternoon. As we look into 2021, we first remain,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot